Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers

Clinical trial NCT00332956 · COMPLETED

Trial details

NCT number: NCT00332956
Sponsor: DynPort Vaccine Company LLC, A GDIT Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2006-05-01
Primary completion: 2008-02-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.